Alpha Teknova, Inc. (Nasdaq: TKNO), an SEC filer in In Vitro & In Vivo Diagnostic Substances, closed at $7.31, +1.2%, on 2026-08-27, with a market cap of $392M, a return on equity of -22.8%, a net margin of -42.6% and 3-year sales growth of -0.7%. Institutional ownership, earnings history and filed financials are on the tabs below.
From 749 daily returns, 3y. Click a metric for its method.
| Ann. Volatility | 92.14% | Sharpe | 0.88 |
| Sortino | 1.49 |
| Beta | 1.11 | Correlation | 0.11 |
| Up capture | 313.97% | Down capture | −137.41% |
Relative Value shows 0.45 — five years of monthly returns, a fixed window (RV).
| Max Drawdown | −79.61% | Ulcer Index | 43.13 |
| MTD | 46.20% | QTD | 28.70% |
| YTD | 92.37% | Window (ann., 3.0y) | 48.98% |
| Skewness | 1.31 | Excess Kurtosis | 6.30 |
| Omega (θ=0) | 1.17 | Tail Ratio | 1.17 |
| Gain/Pain | 0.17 | Hit Rate | 46.60% |
| Win/Loss | 1.25 | Upside Potential | 0.64 |
| Measure | Hist 95% | Hist 99% | Gauss 95% | Gauss 99% |
|---|---|---|---|---|
| VaR | -7.99% | -11.62% | -9.23% | -13.18% |
| CVaR (ES) | -10.57% | -14.50% | -11.65% | -15.15% |
| VaR (Cornish-Fisher) | — | — | -6.14% | -12.39% |
Losses shown as negatives (a 5% loss is −5%).
| Depth | Peak | Trough | Recovery | Peak→Trough | Trough→Recovery |
|---|---|---|---|---|---|
| -79.61% | 2025-02-05 | 2026-02-17 | ongoing | 258 | — |
| -69.07% | 2024-01-03 | 2024-07-05 | 2024-07-26 | 126 | 15 |
| -40.13% | 2023-09-27 | 2023-10-30 | 2023-12-07 | 23 | 27 |
| -25.06% | 2023-08-28 | 2023-09-07 | 2023-09-25 | 7 | 12 |
| -24.74% | 2024-11-11 | 2024-11-18 | 2024-11-20 | 5 | 2 |
| -18.38% | 2024-08-21 | 2024-09-09 | 2024-10-11 | 12 | 24 |
| -17.82% | 2024-12-16 | 2024-12-19 | 2024-12-26 | 3 | 4 |
| -16.89% | 2025-01-06 | 2025-01-16 | 2025-01-27 | 7 | 6 |
| -12.99% | 2024-07-26 | 2024-08-01 | 2024-08-09 | 4 | 6 |
| -12.71% | 2024-08-09 | 2024-08-14 | 2024-08-16 | 3 | 2 |
Worst depth first · lengths in trading days.
